Literature DB >> 26264889

Natural killer cells regulate T cell immune responses in primary biliary cirrhosis.

Shinji Shimoda1, Satomi Hisamoto1, Kenichi Harada2, Sho Iwasaka1, Yong Chong1, Minoru Nakamura3, Yuki Bekki4, Tomoharu Yoshizumi4, Ken Shirabe4, Toru Ikegami4, Yoshihiko Maehara4, Xiao-Song He5, M Eric Gershwin5, Koichi Akashi1.   

Abstract

UNLABELLED: The hallmark of primary biliary cirrhosis (PBC) is the presence of autoreactive T- and B-cell responses that target biliary epithelial cells (BECs). Biliary cell cytotoxicity is dependent upon initiation of innate immune responses followed by chronic adaptive, as well as bystander, mechanisms. Critical to these mechanisms are interactions between natural killer (NK) cells and BECs. We have taken advantage of the ability to isolate relatively pure viable preparations of liver-derived NK cells, BECs, and endothelial cells, and studied interactions between NK cells and BECs and focused on the mechanisms that activate autoreactive T cells, their dependence on interferon (IFN)-γ, and expression of BEC major histocompatibility complex (MHC) class I and II molecules. Here we show that at a high NK/BEC ratio, NK cells are cytotoxic for autologous BECs, but are not dependent on autoantigen, yet still activate autoreactive CD4(+) T cells in the presence of antigen presenting cells. In contrast, at a low NK/BEC ratio, BECs are not lysed, but IFN-γ production is induced, which facilitates expression of MHC class I and II molecules on BEC and protects them from lysis upon subsequent exposure to autoreactive NK cells. Furthermore, IFN-γ secreted from NK cells after exposure to autologous BECs is essential for this protective function and enables autoreactive CD4(+) T cells to become cytopathic.
CONCLUSIONS: NK cell-mediated innate immune responses are likely critical at the initial stage of PBC, but also facilitate and maintain the chronic cytopathic effect of autoantigen-specific T cells, essential for progression of disease.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 26264889      PMCID: PMC4681684          DOI: 10.1002/hep.28122

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  51 in total

Review 1.  Primary biliary cirrhosis.

Authors:  Marshall M Kaplan; M Eric Gershwin
Journal:  N Engl J Med       Date:  2005-09-22       Impact factor: 91.245

2.  Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis.

Authors:  Ya-Hui Chuang; Zhe-Xiong Lian; Koichi Tsuneyama; Bor-Luen Chiang; Aftab A Ansari; Ross L Coppel; M Eric Gershwin
Journal:  J Autoimmun       Date:  2006-05-26       Impact factor: 7.094

3.  T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis.

Authors:  Jorge Allina; Bin Hu; Daniel M Sullivan; Maria Isabel Fiel; Swan N Thung; Steven F Bronk; Robert C Huebert; Judy van de Water; Nicholas F LaRusso; M E Gershwin; Gregory J Gores; Joseph A Odin
Journal:  J Autoimmun       Date:  2007-01-10       Impact factor: 7.094

4.  Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases.

Authors:  Takashi Kamihira; Shinji Shimoda; Minoru Nakamura; Teruhumi Yokoyama; Yasushi Takii; Akira Kawano; Mizuki Handa; Hiromi Ishibashi; M Eric Gershwin; Mine Harada
Journal:  Hepatology       Date:  2005-01       Impact factor: 17.425

5.  Autoreactive T-cell responses in primary biliary cirrhosis are proinflammatory whereas those of controls are regulatory.

Authors:  Shinji Shimoda; Fumihiko Ishikawa; Takashi Kamihira; Atsumasa Komori; Hiroaki Niiro; Eishi Baba; Kenichi Harada; Kumiko Isse; Yasuni Nakanuma; Hiromi Ishibashi; M Eric Gershwin; Mine Harada
Journal:  Gastroenterology       Date:  2006-08       Impact factor: 22.682

6.  Death receptor 5 mediated-apoptosis contributes to cholestatic liver disease.

Authors:  Kazuyoshi Takeda; Yuko Kojima; Kenichi Ikejima; Kenichi Harada; Shunhei Yamashina; Kyoko Okumura; Tomonori Aoyama; Steffen Frese; Hiroko Ikeda; Nicole M Haynes; Erika Cretney; Hideo Yagita; Noriyoshi Sueyoshi; Nobuhiro Sato; Yasuni Nakanuma; Mark J Smyth; Ko Okumura
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-30       Impact factor: 11.205

Review 7.  The causes of primary biliary cirrhosis: Convenient and inconvenient truths.

Authors:  M Eric Gershwin; Ian R Mackay
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

Review 8.  The unfinished business of primary biliary cirrhosis.

Authors:  Carlo Selmi; Massimo Zuin; M Eric Gershwin
Journal:  J Hepatol       Date:  2008-07-02       Impact factor: 25.083

9.  Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells.

Authors:  Shinji Shimoda; Kenichi Harada; Hiroaki Niiro; Tomoharu Yoshizumi; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara; Koichi Tsuneyama; Minoru Nakamura; Atsumasa Komori; Kiyoshi Migita; Yasuni Nakanuma; Hiromi Ishibashi; Carlo Selmi; M Eric Gershwin
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

10.  Adaptive immune features of natural killer cells.

Authors:  Joseph C Sun; Joshua N Beilke; Lewis L Lanier
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

View more
  26 in total

Review 1.  Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2018-04-18       Impact factor: 3.199

Review 2.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

3.  Endogenous IL-10 maintains immune tolerance but IL-10 gene transfer exacerbates autoimmune cholangitis.

Authors:  Yu-Hsin Hsueh; Hung-Wen Chen; Bi-Jhen Syu; Chia-I Lin; Patrick S C Leung; M Eric Gershwin; Ya-Hui Chuang
Journal:  J Autoimmun       Date:  2018-09-28       Impact factor: 7.094

4.  Elevation of Vδ1 T cells in peripheral blood and livers of patients with primary biliary cholangitis.

Authors:  F Hua; L Wang; X Rong; Y Hu; J M Zhang; W He; F C Zhang
Journal:  Clin Exp Immunol       Date:  2016-09-09       Impact factor: 4.330

5.  Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice.

Authors:  G-X Yang; Y Sun; K Tsuneyama; W Zhang; P S C Leung; X-S He; A A Ansari; C Bowlus; W M Ridgway; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2016-06-06       Impact factor: 4.330

6.  Dysregulation of peritoneal cavity B1a cells and murine primary biliary cholangitis.

Authors:  Yan-Qing Yang; Wei Yang; Yuan Yao; Hong-Di Ma; Yin-Hu Wang; Liang Li; Qingfa Wu; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Oncotarget       Date:  2016-05-10

Review 7.  The role of natural killer cells in liver inflammation.

Authors:  A J Highton; I S Schuster; M A Degli-Esposti; M Altfeld
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

8.  Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis.

Authors:  Ana Lleo; Peter Jepsen; Emanuela Morenghi; Marco Carbone; Luca Moroni; Pier Maria Battezzati; Mauro Podda; Ian R Mackay; M Eric Gershwin; Pietro Invernizzi
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

9.  Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens.

Authors:  Aleksandar Arsenijevic; Marija Milovanovic; Jelena Milovanovic; Bojana Stojanovic; Natasa Zdravkovic; Patrick S C Leung; Fu-Tong Liu; M Eric Gershwin; Miodrag L Lukic
Journal:  Sci Rep       Date:  2016-03-21       Impact factor: 4.379

Review 10.  The changing faces of cholangitis.

Authors:  Sum P Lee; Joseph R Roberts; Rahul Kuver
Journal:  F1000Res       Date:  2016-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.